Animal Model Market is projected to reach US$ 2.4 Bn by 2028, registering a healthy CAGR of 6.6% from 2022 to 2028
[170 Pages Report] The global Animal Model Market is estimated to be valued at US$ 1.7 Bn in 2022, and is projected to reach US$ 2.4 Bn by 2028, registering a healthy CAGR of 6.6% from 2022 to 2028.
|Animal Model Market Size (2022)||US$ 1.7 Bn|
|Sales Forecast (2028)||US$ 2.4 Bn|
|Global Market Growth Rate (2022 to 2028)||6.6% CAGR|
|Share of Top 5 Animal Model Suppliers||50%|
Demand for animal models in academic and research institutions is likely to increase at a CAGR of 7% over the assessment period of 2022 to 2028.
Animal Model Demand Analysis (2013 to 2021) Compared to Market Outlook (2022 to 2028)
The global animal model market witnessed a growth rate of 5.3% over the historical period of 2013 to 2021.
Ask for the Brochure: https://www.futuremarketinsights.com/reports/sample/rep-gb-3141
Animals and human beings share a common biological as well as physiological structure. Animals possess a shorter life cycle; however, they have a high genotype resemblance. It is simple and easy to control the animal environment as compared to human beings.
Animal models are increasingly being used in biomedical research that helps to develop new treatment methods for various diseases. Leveraging animal models offer a better understanding of different diseases, along with the efficacy of drugs with regard to the diseases. Owing to these factors, demand for animal models has been witnessing a significant surge in the healthcare sector.
Alternatives such as cell cultures, tissue cultures, and computer models are also available, however, animal models are more preferred owing to the complexity of the living systems. This further makes animal models an effective choice for biomedical research.
Development of animal models that are more predictive in being effective is an iterative process. However, progress is being made, with researchers applying new experimental approaches to elucidate the biology of specific diseases for creating new and efficient animal model systems.
During the development of new drugs dedicated to complex diseases, researchers are being well advised for testing drugs in model organisms as well as in mouse strains with different genetic backgrounds.
Growing adoption of animal models in drug development as well as rising demand for efficient animal models are driving the market growth.
Based on the aforementioned factors, the global animal model market is projected to expand at 6.6% CAGR from 2022 to 2028.
What is Fueling Demand for Animal Models in North America?
The market in North America is expected to account for over 38% of the global market share by 2022.
Significant investments are being made in animal model research in North America, along with relevant policies being reformed by the government to spur funding plans related to animal model research.
Several leading animal model solution providers in North America are expected to make huge investments in biogenic researches. North America will continue to be the most lucrative market for animal models.
What Potential Does the U.S. Animal Model Market Have?
The United States is likely to be a dominating country in the animal model market because of growth in experimental services by biotech and pharmaceutical firms through drug discovery, rise in CROs’ use of animal models, and an increased focus on personalized medications.
As per clinical trials.gov, nearly 293,321 studies were registered at the beginning of the year and around 32,523 studies were registered at the end of the year in 2019. Furthermore, according to the Pharmaceutical Research and Manufacturers of America, biopharmaceutical businesses spent roughly US$ 79.6 Bn on R&D in the United States in 2018.
As a result, the pharmaceutical analytical testing market in the U.S. is predicted to develop in response to the growing number of clinical trials and large investments in these studies.
What is the Market Scenario of Animal Models in China?
The market in China holds a major value share in the global market and is likely to maintain its dominance over the forecast period due to an increase in the number of programs and rising government spending on overall R&D of pharmaceuticals utilizing animal models, as well as the implications of mouse clinical trials (MCTs) for more accurately estimating outcomes.
Moreover, the market is expected to rise due to continued advances in animal models, the availability of modern healthcare systems, and a considerable increase in demand for modern healthcare facilities.
Furthermore, animal model demand is predicted to rise due to a surge in top manufacturers’ concentration on increasing their geographical presence to gain a large market share.
Which Species Type is Expected to Dominate Animal Model Activities?
On the basis of species, revenue from rat-based animal models is projected to account for over 40% share of the market share by 2028. Revenue from the use of rats in animal models is also slated to expand at the highest CAGR through 2028.
Growing adoption of rat models to study a variety of complicated illnesses, rising demand for rat models in biomedical research to better understand current health challenges, and developments in gene-editing techniques are fueling the market expansion.
Increased use of personalized medicine, continued government support in the form of funding and subsidies, and increased use of the rat model in drug development and discovery are the primary factors driving the market growth.
Which End User is Expected to Drive Most Demand for Animal Model Systems?
Academic and research institutions are anticipated to remain the fastest-expanding end users of animal models. Academic and research institutions account for over 50% share of the animal model industry.
Government intervention in academic and research institutions is rising for developing standard protocols related to animal models
Essential requirement for animal research for achieving progress in healthcare and medical science is well-proven, which, in turn, has gained support from researchers. Rapid advancements in novel technologies have made animal models easy and constructive.
Significant incidence rates of diseases, along with adverse effects of drugs have driven the adoption of animal models for ensuring the safety of humans. In addition, increasing government intervention in research institutes for the development of standard protocols associated with animal models will fuel the expansion of the market.
Researchers utilize animal models for basic research such as developing new therapeutic strategies to treat human diseases, for drug discovery which includes target identification & validation, toxicology drug screening & lead optimization & safety screening, and preclinical analyses of drug safety & efficacy.
Impact of COVID-19 Crisis
The animal model market had been facing tremendous pressure from animal welfare organizations and activists in various countries before the outbreak of the COVID-19 pandemic. However, the situation has changed drastically since the outbreak of COVID-19.
This change in situation is since animal model testing was, and remains, central in research towards developing an effective vaccine against the COVID-19 virus. This has caused pressure groups to tone down their rhetoric and has also reduced their penetration potential into public discourse over the issue.
Simultaneously, the animal model market has received a major fillip due to rapid research into COVID-19 vaccines. This research is expected to continue in the near future. Furthermore, research into the COVID-19 vaccine has also led to a major boost in the research and development capabilities of major pharmaceutical companies.
Key animal model system providers are focusing on strategic acquisitions, mergers, collaborations, and partnerships to grow their client base and boost their industrial position. Recent investments by major companies have created prospects for the market to expand globally.
- In January 2020, Horizon Discovery Group plc. confirmed a partnership and license deal with Mammoth Biosciences to gain access to Mammoth’s unique CRISPR technology, and, as a result, make it easier to provide a new generation of genetically altered CHO cells for the manufacture of biotherapeutics such as therapeutic antibodies.
Animal Model Industry Report Scope
|Historical Data Available for||2013-2021|
|Market Analysis||Value in US$ Mn|
|Key Regions Covered||
|Key Countries Covered||
|Key Market Segments Covered||
|Key Companies Profiled||
|Pricing||Available upon Request|
Key Segments of Animal Model Industry Research
Animal Model Market by Species:
- Guinea Pigs
- Other Species
Animal Model Market by End User:
- Academic & Research Institutions
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations (CROs)
- Other End Users
Animal Model Market by Application:
- Basic and Applied Research
- Drug Discovery/Development
Ask for the Complete TOC of this Report: https://www.futuremarketinsights.com/reports/animal-model-market/table-of-content
Animal Model Market by Region:
- North America Animal Model Market
- Latin America Animal Model Market
- Europe Animal Model Market
- East Asia Animal Model Market
- South Asia & Pacific Animal Model Market
- Middle East & Africa (MEA) Animal Model Market
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: [email protected]
For Media Enquiries: [email protected]
Published Sat, 12 Mar 2022 01:19:35 -0600